Monday - July 14, 2025

LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Xilio Therapeutics (NASDAQ: XLO)

Follow NASDAQ:XLO Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ XLO Xilio Therapeutics
Shannon James Samuel / director
06/17/2025
Buy
$0.69
25,000
$17K
70,000
NASDAQ XLO Xilio Therapeutics
Shannon James Samuel / director
06/16/2025
Buy
$0.69
45,000
$31K
45,000
NASDAQ XLO Xilio Therapeutics
Russo Rene / director, officer: PRESIDENT AND CEO
06/16/2025
Buy
$0.68
36,289
$25K
281,172
NASDAQ XLO Xilio Therapeutics
ROSS ROBERT W. / director
06/11/2025
Buy
$0.69
31,000
$21K
31,000
NASDAQ XLO Xilio Therapeutics
Brennan Aoife / director
06/11/2025
Buy
$0.69
31,000
$21K
31,000
NASDAQ XLO Xilio Therapeutics
Bonstein Sara / director
06/11/2025
Buy
$0.69
31,000
$21K
31,000
NASDAQ XLO Xilio Therapeutics
Curran Daniel J. / director
06/11/2025
Buy
$0.69
31,000
$21K
31,000
NASDAQ XLO Xilio Therapeutics
Clancy Paul J / director
06/11/2025
Buy
$0.69
31,000
$21K
31,000
NASDAQ XLO Xilio Therapeutics
Xu Yuan / director
06/11/2025
Buy
$0.69
31,000
$21K
31,000
NASDAQ XLO Xilio Therapeutics
Shannon James Samuel / director
06/11/2025
Buy
$0.69
31,000
$21K
31,000
NASDAQ XLO Xilio Therapeutics
Rossi Christina / director
06/11/2025
Buy
$0.69
31,000
$21K
31,000
NASDAQ XLO Xilio Therapeutics
Bello Akintunde Olatokumbo / director
06/10/2025
Buy
$0.70
62,000
$43K
62,000
NASDAQ XLO Xilio Therapeutics
GILEAD SCIENCES, INC. / 10 percent owner
06/05/2025
Buy
$0.0001
13.34M
$1K
23.31M
NASDAQ XLO Xilio Therapeutics
GILEAD SCIENCES, INC. / 10 percent owner
06/05/2025
Buy
$0.75
13.34M
$10.001M
13.34M
NASDAQ XLO Xilio Therapeutics
GILEAD SCIENCES, INC. / 10 percent owner
06/05/2025
Buy
$0.75
13.34M
$10.001M
13.34M
NASDAQ XLO Xilio Therapeutics
GILEAD SCIENCES, INC. / 10 percent owner
06/05/2025
Buy
$0.75
13.34M
$10.001M
13.34M

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous